Pharmedic Laboratories Ltd Lahore products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Lahore · Pakistan
Lahore pharmaceutical manufacturer established in 1982 with domestic and export operations across multiple therapeutic areas.
Pharmedic Laboratories Ltd Lahore products in Pakistan
Pharmedic Laboratories (Pvt.) Ltd Lahore has 122 medicine presentations registered in Pakistan under 80 brands, covering 70 generic medicines. Most of its products are in Anti-infectives, Oncology & immunology and CNS & mental health. Its brands with the most registered strengths and packs are CEFOTRIM (Ceftriaxone), PACLITAX (Paclitaxel (albumin-bound nanoparticles)), PHARMATREXATE (Methotrexate) and TAXIRON (Cefotaxime). 122 products have an official DRAP price on MedInfoBase. See all 80 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Pharmedic Laboratories (Pvt.) Limited
- Company type
- Private pharmaceutical manufacturer
- Address
- 16 KM Multan Road, Lahore 53800, Pakistan · 53800
- Website
- pharmedic.com ↗
- Phone
- +92 42 37511861-65
- info@pharmedic.com
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Pharmedic Laboratories (Pvt.) Ltd Lahore is priced against the market
86 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Amotrip | Amitriptyline | 25 mg | Tablet | 10x10’s | 028669 | PKR 202.34 | PKR 2.02/tablet | 🔒 Pharma Pro |
| ANTIVAR | Entecavir | 0.5 mg | Tablet | 30’s | 074236 | PKR 12,619.75 | PKR 420.66/tablet | 🔒 Pharma Pro |
| AZYTHRA | Azithromycin | 200 mg/5 mL | Suspension | 15mL | 085809 | PKR 320.35 | PKR 21.36/mL | 🔒 Pharma Pro |
| AZYTHRA | Azithromycin | 250 mg | Capsule | 10’s | 085810 | PKR 495.08 | PKR 49.51/capsule | 🔒 Pharma Pro |
| Azythra | Azithromycin | 500 mg | Tablet | 6's | 127733 | PKR 533.91 | PKR 88.99/tablet | 🔒 Pharma Pro |
| BENDA | Albendazole | 200 mg | Tablet | 2's | 025801 | PKR 19.41 | PKR 9.71/tablet | 🔒 Pharma Pro |
| BENDASource observed | Albendazole | — | Dry suspension | 10ml | 025802Official source ↗ | No indexed price | — | — |
| BISCA | Bisacodyl | 5 mg | Tablet | 10x10's | 038528 | PKR 72.05 | PKR 0.72/tablet | 🔒 Pharma Pro |
| BLEOCIN | Bleomycin | 15 mg | Injection | 1's | 027850 | PKR 4,002.45 | PKR 4,002.45/vial/unit | No comparator |
| CALCIDIN | Calcium carbonate | 500 mg | Tablet | 10x10’s | 028679 | PKR 168.11 | PKR 1.68/tablet | No comparator |
| CEFOTRIM | Ceftriaxone | 250 mg | Injection | 1's | 027819 | PKR 213.57 | PKR 213.57/vial/unit | 🔒 Pharma Pro |
| CEFOTRIM | Ceftriaxone | 500 mg | Injection | 1's | 027820 | PKR 396.07 | PKR 396.07/vial/unit | 🔒 Pharma Pro |
| CEFOTRIM | Ceftriaxone | 1 g | Injection | 1's | 027821 | PKR 718.35 | PKR 718.35/vial/unit | 🔒 Pharma Pro |
| CEFOTRIM | Ceftriaxone | 2 g | Injection | 1's | 132090 | PKR 873.67 | PKR 873.67/vial/unit | 🔒 Pharma Pro |
| CEFTAZ | Ceftazidime | 250 mg | Injection | 1's | 027834 | PKR 159.95 | PKR 159.95/vial/unit | 🔒 Pharma Pro |
| CEFTAZ | Ceftazidime | 500 mg | Injection | 1's | 027835 | PKR 243.30 | PKR 243.30/vial/unit | 🔒 Pharma Pro |
| CEFTAZ | Ceftazidime | 1 g | Injection | 1's | 027836 | PKR 479.57 | PKR 479.57/vial/unit | 🔒 Pharma Pro |
| CEPLATIN | Cisplatin | 25 mg/vial | Injection | 1's | 017728 | PKR 1,209.85 | PKR 1,209.85/vial/unit | No comparator |
| CEPLATIN | Cisplatin | 50 mg/vial | Injection | 1's | 018071 | PKR 2,421.05 | PKR 2,421.05/vial/unit | No comparator |
| CEPLATIN | Cisplatin | 10 mg/20 mL | Injection | 1's | 019124 | PKR 849.89 | PKR 849.89/vial/unit | 🔒 Pharma Pro |
| CIPLOX | Ciprofloxacin | 250 mg | Tablet | 10’s | 014837 | PKR 350.67 | PKR 35.07/tablet | 🔒 Pharma Pro |
| CIPLOX | Ciprofloxacin | 500 mg | Tablet | 10’s | 016069 | PKR 617.19 | PKR 61.72/tablet | 🔒 Pharma Pro |
| CIPLOX INF | Ciprofloxacin | 2 mg/mL | IV infusion | 1's | 016743 | PKR 310.64 | PKR 310.64/vial/unit | No comparator |
| CISTAZINESource observed | Cetirizine | 1 mg | Held for normalizationSource reported: Tablet · structural field conflict | 60ml | 027837Official source ↗ | No indexed price | — | — |
| CISTAZINE | Cetirizine | 10 mg | Tablet | 10’s | 027838 | PKR 81.54 | PKR 8.15/tablet | 🔒 Pharma Pro |
| CLOMINOL | Clomifene citrate | 50 mg | Tablet | 10's | 069254 | PKR 419.36 | PKR 41.94/tablet | 🔒 Pharma Pro |
| CYCLOMIDE | Cyclophosphamide | 500 mg | Injection | 1’s | 026404 | PKR 416.27 | PKR 416.27/vial/unit | No comparator |
| CYCLOMIDE | Cyclophosphamide | 1 g | Injection | 1’s | 026909 | PKR 2,354.45 | PKR 2,354.45/vial/unit | No comparator |
| CYTOCIN | Cytarabine | 100 mg | Injection | 5’s | 038247 | PKR 1,456.12 | PKR 291.22/vial/unit | 🔒 Pharma Pro |
| CYTOCIN | Cytarabine | 500 mg | Injection | 1’s | 038298 | PKR 970.75 | PKR 970.75/vial/unit | 🔒 Pharma Pro |
| D-BLASTIN | Daunorubicin HCl | 20 mg | Injection | 1's | 026405 | PKR 2,118.19 | PKR 2,118.19/vial/unit | 🔒 Pharma Pro |
| D-RUBICIN | Doxorubicin | 10 mg | Injection | 1's | 045501 | PKR 771.43 | PKR 771.43/vial/unit | 🔒 Pharma Pro |
| D-RUBICIN | Doxorubicin | 50 mg | Injection | 1's | 045502 | PKR 2,635.77 | PKR 2,635.77/vial/unit | 🔒 Pharma Pro |
| DACTINOFIN | Dactinomycin | 500 mcg/vial | Injection | 1’s | 042971 | PKR 465.96 | PKR 465.96/vial/unit | No comparator |
| DARBAZINE | Dacarbazine | 200 mg | Injection | 1’s | 026908 | PKR 925.05 | PKR 925.05/vial/unit | 🔒 Pharma Pro |
| DARVIN | Tramadol + Paracetamol | 37.5 mg + 325 mg | Tablet | 10’s | 074232 | PKR 194.15 | PKR 19.42/tablet | 🔒 Pharma Pro |
| Dex-Lansor 30mg CapsuleRegistry verified | Dexlansoprazole dual delayed release pellets 22.5% eq. to Dexlansoprazole | — | — | — | 135442Official source ↗ | No indexed price | — | — |
| Dex-Lansor 60mg CapsuleRegistry verified | Dexlansoprazole dual delayed release pellets 22.5% eq. to Dexlansoprazole | — | — | — | 135443Official source ↗ | No indexed price | — | — |
| DIABIN | Metformin | 500 mg | Tablet | 10x10’s | 006923 | PKR 316.06 | PKR 3.16/tablet | 🔒 Pharma Pro |
| DIABIN | Metformin | 850 mg | Tablet | 5x10’s | 027741 | PKR 224.04 | PKR 4.48/tablet | 🔒 Pharma Pro |
| DOZEP | Docetaxel | 20 mg | Injection | 20mg/vial | 048974 | PKR 15,532.00 | — | No comparator |
| DOZOPRIM | Citalopram | 20 mg | Tablet | 14's | 053793 | PKR 693.12 | PKR 49.51/tablet | 🔒 Pharma Pro |
| Epsol 40mg InjectionRegistry verified | Esomeprazole as sodium | — | — | — | 111616Official source ↗ | No indexed price | — | — |
| FilgrasSource observed | Filgrastim (rHuG-CSF) | — | Injection | 1ml | 048065Official source ↗ | No indexed price | — | — |
| FLOSTIN | Fluoxetine | 20 mg | Tablet | 10's | 074233 | PKR 126.68 | PKR 12.67/tablet | 🔒 Pharma Pro |
| FLUPHAN | Fluphenazine | 25 mg/mL | Injection | 5x1mL | 028673 | PKR 679.52 | PKR 135.90/mL | No comparator |
| Gemtek-200Source observed | Gemcitabine | — | Injection | 1's | 049192Official source ↗ | No indexed price | — | — |
| GLIFEN | Glibenclamide | 5 mg | Tablet | 6x10’s | 028678 | PKR 168.11 | PKR 2.80/tablet | 🔒 Pharma Pro |
| HYDROUREA | Hydroxyurea | 500 mg | Capsule | 100's | 026407 | PKR 2,883.13 | PKR 28.83/capsule | 🔒 Pharma Pro |
| IFOSFAMIN | Ifosfamide | 1 g/vial | Injection | 1's | 028105 | PKR 2,329.80 | PKR 2,329.80/vial/unit | No comparator |
All 80 Pharmedic Laboratories Ltd Lahore brands in Pakistan
- Amotrip Amitriptyline · 25 mg tablet
- ANTIVAR Entecavir · 0.5 mg tablet
- AZYTHRA Azithromycin · 200 mg/5 mL suspension, 250 mg capsule, 500 mg tablet
- BENDA Albendazole · 200 mg tablet
- BISCA Bisacodyl · 5 mg tablet
- BLEOCIN Bleomycin · 15 mg injection
- CALCIDIN Calcium carbonate · 500 mg tablet
- CEFOTRIM Ceftriaxone · 1 g injection, 2 g injection, 250 mg injection
- CEFTAZ Ceftazidime · 1 g injection, 250 mg injection, 500 mg injection
- CEPLATIN Cisplatin · 10 mg/20 mL injection, 25 mg/vial injection, 50 mg/vial injection
- CIPLOX Ciprofloxacin · 250 mg tablet, 500 mg tablet
- CIPLOX INF Ciprofloxacin · 2 mg/mL infusion
- CISTAZINE Cetirizine · 10 mg tablet
- CLOMINOL Clomifene citrate · 50 mg tablet
- CYCLOMIDE Cyclophosphamide · 1 g injection, 500 mg injection
- CYTOCIN Cytarabine · 100 mg injection, 500 mg injection
- D-BLASTIN Daunorubicin HCl · 20 mg injection
- D-RUBICIN Doxorubicin · 10 mg injection, 50 mg injection
- DACTINOFIN Dactinomycin · 500 mcg/vial injection
- DARBAZINE Dacarbazine · 200 mg injection
- DARVIN Tramadol + Paracetamol · 37.5 mg + 325 mg tablet
- DIABIN Metformin · 500 mg tablet, 850 mg tablet
- DOZEP Docetaxel · 20 mg injection
- DOZOPRIM Citalopram · 20 mg tablet
- FLOSTIN Fluoxetine · 20 mg tablet
- FLUPHAN Fluphenazine · 25 mg/mL injection
- GLIFEN Glibenclamide · 5 mg tablet
- HYDROUREA Hydroxyurea · 500 mg capsule
- IFOSFAMIN Ifosfamide · 1 g/vial injection, 2 g/vial injection
- KALIDIX Clarithromycin · 250 mg tablet, 500 mg tablet
- LARSEN Losartan · 50 mg tablet
- LARSEN-T Losartan + Hydrochlorothiazide · 50 mg + 12.5 mg tablet
- LETTROZONE Letrozole · 2.5 mg tablet
- LEUCOCIN Calcium folinate (folinic acid) · 15 mg/mL injection, 50 mg/mL injection
- LYCAS Lidocaine · 1 % injection
- MALAFANTRINE Artemether + Lumefantrine · 20 mg + 120 mg tablet
- MALAFANTRINE-PF Artemether + Lumefantrine · 40 mg + 240 mg tablet
- MALAREST Sulfadoxine + Pyrimethamine · 500 mg + 25 mg tablet
- MALASAN Artemether · 40 mg capsule, 80 mg/mL injection
- Marena Meropenem · 1 g injection, 500 mg injection
- MEGAZOL Metronidazole + Diloxanide furoate · 400 mg + 500 mg tablet
- MELPHA Melphalan · 2 mg tablet
- MERCAPRINE Mercaptopurine · 50 mg tablet
- MESNAL Mesna · 100 mg/mL injection
- MICAZOL Metronidazole + Diloxanide furoate · 200 mg + 250 mg tablet
- MICROGEN Metronidazole · 500 mg injection
- MICROGIN Metronidazole · 400 mg tablet
- MODRIN Nortriptyline + Fluphenazine · 10 mg + 1 mg tablet
- MOXEF Moxifloxacin · 400 mg tablet
- NILCID Omeprazole, Esomeprazole · 20 mg capsule, 40 mg injection
- NILCID-40 Omeprazole · 40 mg capsule
- ONSET Ondansetron · 2 mg/mL injection
- ONSET-8 Ondansetron · 8 mg tablet
- PACLITAX Paclitaxel (albumin-bound nanoparticles) · 100 mg injection, 150 mg injection, 30 mg injection
- Paracetamol Paracetamol · 500 mg tablet
- PHARMACRISTINE Vincristine sulfate · 1 mg/mL injection
- PHARMAPLATIN Carboplatin · 150 mg/15 mL injection, 200 mg injection
- PHARMATREXATE Methotrexate · 10 mg tablet, 2.5 mg tablet, 50 mg/vial injection
- PHARMAURACIL Fluorouracil (5-FU) · 25 mg/mL injection
- PHARMAURACIL 5 Fluorouracil (5-FU) · 25 mg/mL injection
- PHARMAZORINE Azathioprine · 50 mg tablet
- PHARMEDIC HY-CHLOR Hydroxychloroquine · 200 mg tablet
- PHRENIA Haloperidol · 1.5 mg tablet, 5 mg/mL injection
- PHRENIA-5 Haloperidol · 5 mg tablet
- PLAXINOL Oxaliplatin · 50 mg/vial injection
- PROCARBIZOLE Propylthiouracil · 50 mg tablet
- Procef Cefixime · 200 mg tablet, 400 mg tablet
- Procef DS Cefixime · 200 mg/5 mL suspension
- PROCEF DSP Cefixime · 100 mg/5 mL suspension
- REGELAN Metoclopramide · 10 mg/2 mL injection
- RISHA Risperidone · 1 mg tablet, 2 mg tablet, 4 mg tablet
- TAMOX-10 Tamoxifen · 10 mg tablet
- TAMOX-20 Tamoxifen · 20 mg tablet
- TAXIRON Cefotaxime · 1000 mg/vial injection, 125 mg/vial injection, 250 mg/vial injection
- TOPOSIDE Etoposide · 20 mg/mL injection
- TRANQUIL Lorazepam · 1 mg tablet, 2 mg tablet
- VASODIL Amlodipine · 5 mg tablet
- VINBLAS Vinblastine · 10 mg/vial injection
- VIRAZIDE Ribavirin · 100 mg tablet, 400 mg tablet, 600 mg tablet
- Water for Injection Water for Injection · 10 mL injection
Pharmedic Laboratories Ltd Lahore: common questions
How many products does Pharmedic Laboratories Ltd Lahore have in Pakistan?
Pharmedic Laboratories (Pvt.) Ltd Lahore has 122 registered medicine presentations in Pakistan, sold under 80 brands and covering 70 generic medicines.
What are the main brands of Pharmedic Laboratories Ltd Lahore?
By number of registered strengths and packs, its largest brands are CEFOTRIM (Ceftriaxone), PACLITAX (Paclitaxel (albumin-bound nanoparticles)), PHARMATREXATE (Methotrexate), TAXIRON (Cefotaxime) and AZYTHRA (Azithromycin). This is not a sales ranking.
Which therapy areas does Pharmedic Laboratories Ltd Lahore cover?
The most products are in Anti-infectives (45), Oncology & immunology (39), CNS & mental health (14), Gastrointestinal & hepatology (8) and Endocrine & metabolic (4).
Where can I see Pharmedic Laboratories Ltd Lahore medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.